Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 14, 2007
Boston Scientific Corporation (NYSE: BSX) today released data reflecting experience from the first 15,000 patients(1) monitored wirelessly on the...
-
Sep 6, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Ray Elliott as a Director. Mr. Elliott,...
-
Sep 5, 2007
Boston Scientific Corporation (NYSE: BSX) today announced results from the TAXUS WOMAN study, a gender specific analysis of the...
-
Sep 4, 2007TAXUS® Stent shows no additional very late stent thrombosis
Boston Scientific Corporation (NYSE: BSX) today announced five-year and final results from its TAXUS II clinical trial,...
-
Sep 2, 2007OLYMPIA Launch Phase Results Show Positive Outcomes in Diabetic Patients
Boston Scientific Corporation (NYSE: BSX) today announced one-year results from the European and Intercontinental launch phases...
-
Aug 30, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that three of its subsidiaries, Guidant Corporation, Cardiac Pacemakers Inc. and Guidant...
-
Aug 29, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Aug 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 20th Annual Healthcare Conference, which is being held...
-
Aug 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that it has successfully amended its $2 billion revolving line of credit and $5 billion...
-
Aug 16, 2007Transaction Would Advance Company's Plan to Divest Non-Strategic Assets and Strengthen Operating and Financial Performance
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its Cardiac Surgery and Vascular Surgery businesses...
-
Aug 9, 2007BSC to assume sole control of Pain Management business and emerging indications program, Advanced Bionics principals to purchase Auditory business and drug pump program
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement to amend its merger agreement with Advanced Bionics,...
-
Aug 2, 2007Endosurgery group to remain wholly owned by Boston Scientific
Boston Scientific Corporation (NYSE: BSX) today provided an update on its plans to strengthen operating and financial performance as part of its...
-
Jul 24, 2007
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its fluid management business as part of the...
-
Jul 20, 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2007, as well as guidance for net...
-
Jul 19, 2007TAXUS PERSEUS clinical program to evaluate platinum enhanced drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the beginning of clinical trial enrollment in studies evaluating its third-generation...
-
Jul 17, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the successful implantation of the Company's TAXUS® Petal™ Bifurcation...
-
Jul 13, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that an agreement has been reached to settle claims associated with a series of product...
-
Jul 10, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2007...
-
Jul 2, 2007Hardware and software innovations offer new benefits to physicians and patients
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Precision Plus™ Spinal Cord Stimulation (SCS) System, the world's...
-
Jun 25, 2007
Boston Scientific Corporation (NYSE: BSX) today announced it has signed a definitive agreement to acquire Remon Medical Technologies Inc., a...
-
Jun 21, 2007Deal Follows Successful Four-Year Exclusive Distribution of Prolieve® Thermodilatation System
Boston Scientific Corporation (NYSE: BSX) today announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia...
-
Jun 8, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 28th Annual Healthcare Conference, which is being held June...
-
Jun 4, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of an article in the Journal of American College of Cardiology (JACC)...
-
May 31, 2007Study seeks to confirm the safety and efficacy of systems in routine clinical practice
Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in the SONOMA post-market approval study of the Company's...
-
May 24, 2007Longest drug-eluting stent approved for the management of patients with clinically challenging coronary artery disease
Boston Scientific Corporation (NYSE: BSX) today announced that it has received CE Mark for its TAXUS® Liberte™ Long...